6th Cir.

Apogee Coal Company, LLC v. Director, Office of Workers' Compensation Programs

Apogee Coal Company, LLC v. Director, Office of Workers’ Compensation Programs

April 28, 2026 ·23-3537 ·Published · By Maria Santos

The United States Court of Appeals for the Sixth Circuit denied petitions for review seeking to shift liability for Black Lung Benefits Act payments from a former parent corporation to a successor entity. The court held that the petitioners were bound by a prior published decision rejecting identical arguments based on materially identical facts.

Background

In the nineteen nineties, miners worked for Apogee Coal Company, a subsidiary of Arch Resources, Inc. Arch self-insured Apogee against black-lung claims rather than purchasing commercial insurance. In two thousand and five, Arch sold Apogee and its black-lung liabilities to Magnum Coal. Three years later, Patriot Coal acquired Magnum and its subsidiaries. In two thousand and fifteen, Patriot went bankrupt, creating a risk that black-lung liabilities would shift to the federal government. The Department of Labor instructed its district directors to hold Arch liable as the responsible insurer for claims accrued while it owned and self-insured Apogee. Miners applied for benefits between two thousand and fifteen and two thousand and seventeen. Administrative law judges and the Benefits Review Board affirmed the district directors’ decisions, and Arch petitioned the Sixth Circuit for review.

The court’s reasoning

The court reviewed the Board’s legal conclusions de novo. Petitioners argued that the Board erred in holding Arch liable for benefits owed by Apogee. However, Arch and Apogee conceded that they were making the same arguments based on materially identical facts that the court had rejected in a published decision two years prior. The court noted that the prior decision binds it. Consequently, the court denied the petitions for review.

What it means going forward

The ruling confirms that a parent corporation remains liable for black-lung benefits accrued during its ownership and self-insurance of a subsidiary, even after selling the subsidiary, when the arguments against such liability have already been settled by binding precedent.